Financial Statements/ESG Information - [Interim/Half-Year Report]

China Pioneer Pharma Holdings Ltd is a marketing, promotion and channel management service provider dedicated to imported pharmaceutical products and medical devices in China.

Interim Report 2025

Announcements and Notices - [Dividend or Distribution (Announcement Form)]

Interim Dividend For The Six Months Ended 30 June 2025

Announcements and Notices - [Interim Results / Dividend or Distribution / Prior Period Adjustments due to Correction of Material Errors / Closure of Books or Change of Book Closure Period]

Interim Results Announcement For The Six Months Ended 30 June 2025

Announcements and Notices - [Date of Board Meeting]

Notice Of Board Meeting

Announcements and Notices - [Profit Warning / Inside Information]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

China Pioneer Pharma Holdings (1345 HK)

Interim Report 2025

Interim Dividend For The Six Months Ended 30 June 2025

Interim Results Announcement For The Six Months Ended 30 June 2025

Notice Of Board Meeting

Inside Information Profit Warning

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)